CONNECT: Connecting Cerebral Organoids to the Blood-Brain Barrier

CONNECT: Connecting Cerebral Organoids to the Blood-Brain Barrier

The CONNECT project aims to develop a novel organoid-chip connecting the blood vasculature to the brain to mimic the blood-brain barrier (BBB). This complex 3D-model can be used to mimic aspects of drug delivery into the human brain, a key process that is often not...
Nano+ Project Ends With Promising Results

Nano+ Project Ends With Promising Results

Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. InnoSer has recently finished a project with promising results in understanding altered...
A day in the life of InnoSer Oncology Study Director Kim Frederix

A day in the life of InnoSer Oncology Study Director Kim Frederix

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
InnoSers Ongoing Commitment to the 3Rs

InnoSers Ongoing Commitment to the 3Rs

Throughout modern medicine, animal testing has played a critical role in the development of drugs, vaccines, and surgical techniques. These studies have enabled us to save countless lives and build upon research to ultimately cure patients. Aiming to accelerate the...
Quality Management At InnoSer Services

Quality Management At InnoSer Services

As InnoSer transitions from the startup to scale up phase in its journey, it is also taking a number of steps to ascertain its quality management ambitions. Having dedicated personnel, expanding our current list of certifications, organizing formal audits and...